ED
Endexx Corporation
EDXC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $57.2K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EDXC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/FCF 1.12x
P/S -0.06x
P/FFO N/A
Growth
100 /100
Growing Rev. growth 36.53%
FCF growth N/A
Book val. growth N/A
Profitability
33 /100
Weak Net margin 1,286.87%
Op. margin 10.20%
FCF margin 5.16%
Quality
0 /100
Poor ROA 826.43%
Asset turnover -0.64x
ROIC 0.57%
Debt
0 /100
High Int. coverage -4.39x
Current ratio 0.04x
Net debt/EBITDA N/A
Stability
27 /100
Unstable Rev. volatility 143.16%
EPS volatility 44.15%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EDXC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Brad Listermann
Employees
10
Headquarters
Cave Creek